Basic monosaccharide derivatives: tools for exploring the active site of glycohydrolases and for studies in glycoprotein biosynthesis
نویسندگان
چکیده
The majority of glycoside hydrolases is strongly inhibited by monosaccaride derivatives bearing a basic NH—group adjacent to C—i, i. e. by glycosylanines, 5—amino—5—deoxyhexopyranoses, and 1,5—iminoalditols. This inhibition with Kr—values up to 104—tines smaller than those of neutral analogs is explained by a catalytic site which features an acid and a carboxylated in iuxtaposition close to the anoneric carbon of the bound inhibitor or substrate. The inhibitor protonated by the acid forms an ion pair with the carboxylate. The stability of this ion pair and the lack of influence of added salt on the inhibition calls for an active site strongly shielded from the aqueous environment. The acid/carboxylate arrangement of functional groups is supported by inhibition studies with substrate related epoxides that are activated by proton transfer from the acid and form an ester with carboxylate. N—Alkylation of the basic inhibitors leads, in many cases, to an enhanced inhibition. Structural variation of the alkyl substituents permits a detailed characterisation of the aglycon site as exemplified by studies on lysosomal —glucosidase Inhibition by 1,5—dideoxy—i,5—imino—D—glucitol and —mannitol of D(—glucosi— dases and —mannosidases participating in the biosynthesis of carbohydrate chains linked to asparagine residues of glycoproteins results in altered glycan structures of newly synthesized proteins. The effects of these alteration on surrace expression and secretion of the proteins, on intracellular compartmentation and on the formation and infectivity of enveloped viruses is discussed.
منابع مشابه
طراحی، سنتز، مطالعه داکینگ مولکولی و ارزیابی بیولوژیکی مشتقات هتروآریل 2-فنوکسی پیریدین -3-ایل بهعنوان مهارکننده آنزیم لیپواکسیژناز
Introdution: Lipoxygenase enzyme is responsible for biosynthesis of leukotrienes that possess various pharmacological effects in the body. The beneficial therapeutic effects of lipoxygenase inhibitors have been proved in some diseases such as asthma, cancer and Alzheimer’s disease. So, the lipoxygenase inhibitors could be used in the treatment of some diseases and pathological conditions. In th...
متن کاملDFT Studies and Topological Analyses of Electron Density on Acetophenone and Propiophenone Thiosemicarbazone Derivatives as Covalent Inhibitors of Falcipain-2, a Major Plasmodium Falciparum Cysteine Protease
Thiosemicarbazones (TSCs) possess significant antimalarial properties believed to be linked to the inhibition of major cysteine proteases, such as falcipain-2, in Plasmodium falciparum. However, the binding modes of TSCs to the active site of these enzymes are not clear. As a result of this, the nature of the bonding interactions between the active site of falcipain-2 and different derivatives ...
متن کاملDesign and Docking Study of Some Pyrimidine derivatives as Antimalarial Agents
Background and Aim: According to the latest estimate published by the World Health Organization in 2017, there are 219 million malaria cases and 435,000 deaths. With the emergence of drug-resistant strains in malaria, there is a need for new drug targets every time. In this study, the design and docking study of the pyrimidine derivatives for inhibiting Methionine aminopeptidase1B enzyme (Metap...
متن کاملMechanism-Based Studies of the Active Site-Directed Inhibition and Activation of Enzyme Transketolase
Derivatives of phenyl-keto butenoic acids have been reported to be inhibitors of pyruvate decarboxylase, (PDC). The inhibition of transketolase, a thiamine requiring enzyme such as PDF, by meta nitrophenyl derivative of 2-oxo-3-butenoic acid (MNPB) is reported here. These studies indicate that the inhibitor binds to the enzyme at the active site. A two-step inhibition was observed, first th...
متن کاملDesign, Synthesis, Molecular Modeling Studies and Biological Evaluation of N'-Arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide Derivatives as Novel Anti-HCV Agents
HCV-induced hepatitis is one of the most debilitating diseases. The limited number of anti-HCV drugs and drug-resistance necessitate developing of new scaffolds with different mode of actions. HCV non-structural protein 5B (NS5B) is an attractive target for development of novel inhibitors of HCV replication. In this paper, new N'-arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazi...
متن کامل